Robert Cuddihy

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Faramarz Ismail‐Beigi, Timothy E. Craven, Mary Ann Banerji et al. · The Lancet · 2010 · 1.4K citations

Medicine, Internal Medicine, Diabetology +14

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

Richard E. Pratley, Michael A. Nauck, Timothy S. Bailey et al. · The Lancet · 2010 · 589 citations

Medicine, Endocrinology, Pharmacotherapy +14

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study

M. E Miller, D. E Bonds, Hertzel C. Gerstein et al. · BMJ · 2010 · 428 citations · Full text

Pharmacy, Pharmacotherapy, Pharmacovigilance +9

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

David Russell‐Jones, Robert Cuddihy, M Hanefeld et al. · Diabetes Care · 2011 · 338 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes

W. Timothy Garvey, Luc Van Gaal, Lawrence A. Leiter et al. · Metabolism · 2018 · 268 citations · Full text

Medicine, Endocrinology, Pharmacology +17